Amanda Glickman
Amanda Glickman publishes mostly in Neurology, General Health Professions and Physiology, on topics such as Parkinson's Disease Mechanisms and Treatments, Botulinum Toxin and Related Neurological Disorders and Neurological disorders and treatments.
- World rank
- #7,084,159 of 7,710,434 ranked researchers
- Rank in United States
- #1,581,936 of 1,627,098
- Works
- 29
- Citations
- 188
- Citations per work
- 6.5
What does Amanda Glickman research?
Amanda Glickman's work is mostly in Medicine (46%), Health Professions (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1654.7%
- Medicine1346.4%
- Health Professions28.3%
- Everything else1345.3%
- 1Neurology21% of their works
- 2General Health Professions8% of their works
- 3Physiology8% of their works
- 4Cardiology and Cardiovascular Medicine7% of their works
- 5Pathology and Forensic Medicine5% of their works
- 6Public Health, Environmental and Occupational Health5% of their works
Research topics
- Parkinson's Disease Mechanisms and Treatments
- Botulinum Toxin and Related Neurological Disorders
- Neurological disorders and treatments
- Lysosomal Storage Disorders Research
- Genetic Neurodegenerative Diseases
- Venous Thromboembolism Diagnosis and Management
- Trigeminal Neuralgia and Treatments
- Patient-Provider Communication in Healthcare
Which keywords describe Amanda Glickman's research?
The keywords of their largest research topics: Parkinson's Disease, Treatment, Neurological Disorders, Mitochondrial Dysfunction, a-Synuclein, Botulinum Toxin, Diagnosis and Neurodegeneration.
- Patient-Centered Care
- Trigeminal Neuralgia
- Microvascular Decompression
- Antithrombotic Therapy
- Enzyme Replacement Therapy
- Deep Brain Stimulation
- Neurotoxins
- Diagnosis
- Mitochondrial Dysfunction
- Treatment
- Parkinson's Disease
- Neurological Disorders
- Botulinum Toxin
- Neurodegeneration
- a-Synuclein
- Subthalamic Nucleus
- Lysosomal Storage Disorders
- Huntington's Disease
- Protein Aggregation
- Venous Thromboembolism
- Physician Communication
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 21 words, with their numbers
- Parkinson's Disease153 topics
- Treatment123 topics
- Neurological Disorders112 topics
- Mitochondrial Dysfunction92 topics
- Botulinum Toxin61 topic
- Diagnosis62 topics
- Neurodegeneration61 topic
- Neurotoxins61 topic
- a-Synuclein61 topic
- Deep Brain Stimulation51 topic
- Subthalamic Nucleus51 topic
- Enzyme Replacement Therapy41 topic
- Lysosomal Storage Disorders41 topic
- Antithrombotic Therapy31 topic
- Huntington's Disease31 topic
- Microvascular Decompression31 topic
- Protein Aggregation31 topic
- Trigeminal Neuralgia31 topic
- Venous Thromboembolism31 topic
- Patient-Centered Care21 topic
- Physician Communication21 topic
Where does Amanda Glickman work?
Amanda Glickman's main affiliation in the publication record is Mount Sinai Beth Israel, United States.
How many publications and citations does Amanda Glickman have?
OpenAlex counts 29 works and 188 citations for Amanda Glickman, an h-index of 8, ranking #7,084,159 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Amanda Glickman. Posts are plain text and can be reported.